GGrantIndex
← Leaderboards

Allison Hubel

University Of Minnesota Twin Cities

$5,868,733
Attributed
$9,722,103
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200623
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$9,722,103 · 9

By mechanism

U01$2,991,667 · 1
R01$2,700,002 · 2
R24$2,371,295 · 1
R21$1,000,197 · 3
R25$553,347 · 1
R29$105,595 · 1

Others in their field

Top investigators on “Cells

Research focus

CellsCryopreservationFreezingInvestigationTemperatureCell TherapyAlgorithmsRecoveryRaman Spectrum AnalysisCommunitiesResourcesBiologicalPlantsCold TemperatureMolecularPreservationSuccessDimethyl SulfoxideCostProtocols DocumentationStressOrganismAmino AcidsDroughts

Grant awards (27)

Development of a novel method for cryopreservation of Drosophila melanogaster$593,865
R24 · FY2023 · OD
Multicomponent solutions for the preservation of cell therapy products$385,959
R01 · FY2023 · HL · contact PI
Development of a novel method for cryopreservation of Drosophila melanogaster$603,215
R24 · FY2022 · OD
Multicomponent solutions for the preservation of cell therapy products$392,168
R01 · FY2022 · HL · contact PI
Development of a novel method for cryopreservation of Drosophila melanogaster$575,125
R24 · FY2021 · OD
Multicomponent solutions for the preservation of cell therapy products$396,514
R01 · FY2021 · HL · contact PI
Development of a novel method for cryopreservation of Drosophila melanogaster$599,090
R24 · FY2020 · OD
Multicomponent solutions for the preservation of cell therapy products$405,296
R01 · FY2020 · HL · contact PI
Multicomponent solutions for the preservation of cell therapy products$335,681
R01 · FY2019 · EB · contact PI
Integrated training in development and clinical practice of cell-based therapies$107,012
R25 · FY2019 · HL · contact PI
Multicomponent solutions for the preservation of cell therapy products$337,457
R01 · FY2018 · EB · contact PI
Multicomponent solutions for the preservation of cell therapy products$119,329
R01 · FY2018 · EB · contact PI
Integrated training in development and clinical practice of cell-based therapies$108,340
R25 · FY2018 · HL · contact PI
MIN-REACH Research Evaluation and Commercialization Hub$991,667
U01 · FY2017 · HL
Multicomponent solutions for the preservation of cell therapy products$327,598
R01 · FY2017 · EB · contact PI
Integrated training in development and clinical practice of cell-based therapies$110,652
R25 · FY2017 · HL · contact PI
MIN-REACH Research Evaluation and Commercialization Hub$1,000,000
U01 · FY2016 · HL
Integrated training in development and clinical practice of cell-based therapies$112,506
R25 · FY2016 · HL · contact PI
MIN-REACH Research Evaluation and Commercialization Hub$1,000,000
U01 · FY2015 · HL
Integrated training in development and clinical practice of cell-based therapies$114,837
R25 · FY2015 · HL · contact PI
Technology platform for development of multi-component preservation solution$171,838
R21 · FY2014 · EB · contact PI
Technology platform for development of multi-component preservation solution$215,204
R21 · FY2013 · EB · contact PI
Post thaw assessment of umbilical cord blood$108,528
R21 · FY2013 · HL · contact PI
Post thaw assessment of umbilical cord blood$114,000
R21 · FY2012 · HL · contact PI
Cell Graft Engineering Using Microfluids$179,126
R21 · FY2007 · EB · contact PI
Cell Graft Engineering Using Microfluids$211,501
R21 · FY2006 · EB · contact PI
CRYOBIOPHYSICAL CHARACTERISTICS OF SPHEROIDS$105,595
R29 · FY2000 · GM